Kate Hollingworth

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease

Pier Luigi Paggiaro, Ragnar Dahle, I Bakran et al. · The Lancet · 1998 · 509 citations

Allergy, Advanced Lung Disease, Clinical Trials +5

Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012–2013

Kate Hollingworth, Kourtney J. Davis, Sarah Landis et al. · International Journal of COPD · 2014 · 154 citations · Full text

Efficacy and tolerability of fluticasone propionate nasal drops 400 μg once daily compared with placebo for the treatment of bilateral polyposis in adults

Paul K. Keith, Jyrki Nieminen, Kate Hollingworth et al. · Clinical & Experimental Allergy · 2000 · 107 citations

Continuing to Confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countries

Kate Hollingworth, Kourtney J. Davis, Sarah Landis et al. · International Journal of COPD · 2014 · 66 citations · Full text

Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1)

J.C.M Hoekx, Gunilla Hedlin, Ward A. Pedersen et al. · European Respiratory Journal · 1996 · 61 citations · Full text

Asthma, Allergy, Asthmatic Children +13